Narrative: Immunology

Sentiment: Pharma Market Shift, Vaccine Development

Analysis Date: May 2, 2026

The immunology pharmaceutical market is shifting, with newer drugs like Skyrizi and Rinvoq driving AbbVie's revenue and offsetting Humira's decline. Advanced vaccine development, specifically an mRNA vaccine for H5N1, is also underway.

["AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline" "newer immunology drugs Skyrizi and Rinvoq" "mRNA vaccine for H5N1"]